ACOR - Acorda Therapeutics GAAP EPS of -$0.69 beats by $0.42 revenue of $22.25M misses by $8.76M
2023-05-11 16:02:55 ET
- Acorda Therapeutics press release ( NASDAQ: ACOR ): Q1 GAAP EPS of -$0.69 beats by $0.42 .
- Revenue of $22.25M (-1.2% Y/Y) misses by $8.76M .
For further details see:
Acorda Therapeutics GAAP EPS of -$0.69 beats by $0.42, revenue of $22.25M misses by $8.76M